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ABSTRACT 
This study presents a new procedure to control the depth of anaesthesia by adjusting the amount of 
medication given to the patient to improve the recovery from anaesthesia. The procedure is based 
on model based predictive control technique, and the method is validated using measured clinical 
signals of BIS. Comparing to PID and internal model control, the proposed new method improves 
the performance of the closed-loop system in reference tracking, overall stability and uncertainties 
of the patient models and parameters.  
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1. INTRODUCTION 
Many surgical procedures would not be possible 
without the patient entering a state of 
unconsciousness. The essential features of a 
successful general anaesthesia, displayed by the 
patient, are a reversible loss of consciousness with a 
lack of movement, a lack of awareness, 
unresponsiveness to painful stimuli and a lack of 
recall of the surgical intervention. Inadequate 
general anaesthesia may lead to intra-operative 
awareness with recall (due to patient under dosage) 
or to prolonged recovery and an increased risk of 
postoperative complications for the patient (due to 
over dosage).The process of monitoring depth of 
anaesthesia and administration of a general 
anaesthetic during surgery is a closed-loop control 
system where the human is responsible for 
reasoning and action. Anaesthetists play the roles of 
controller and actuator by deciding on the amount 
of anaesthetic and when to administer it. On the 
other hand, the activity of monitoring is performed 
automatically by commercially available depth of 
anaesthesia monitors. Together they form a closed-
loop control system. The proposed control systems 
are most often built around a well established BIS 
monitor, which is now standard equipment for 
anaesthesia monitoring. A well designed automatic 
control system can avoid both over and under-
dosage of the drugs, which minimizes the drug 
consumption, intra-operative awareness and 
recovery times, thereby decreasing the cost of the 
surgery and the cost of the postoperative care.  
Absalom et al. (2003) produced a closed-loop 
control system of anaesthesia that uses BIS as the 
control variable to automatically control the target 
blood concentration of Propofol (Target Controlled 
Infusion (TCI) system). The system was able to 
provide clinically sufficient anaesthesia in all 
patients, with enhanced accuracy of control. There 
was a tendency for more accurate control in those 
patients in whom the control algorithm incorporated 
effect-site steering (Absalom and Kenny, 2003); 
(Engdahl et al., 1998). A method and an algorithm 
are proposed for controlling the effect site 
concentration using a TCI method. The method 
limits the peak plasma concentration, thereby 
slowing the start of anaesthetic drug effect but 
potentially improving side effects. Simulation is 
used to observe the delay in time to peak effect for 
five types of anaesthetic drug when the peak plasma 
concentration is limited by the algorithm; the 
control system was evaluated in 30 patient cases. 
This study clearly suggests the desirability of 
individual tuning of the controller parameters. 
 
A method for an enhanced tuning of the PID 
controller parameters to the patient’s individual 
dynamics was presented by Mendonca & Lago 
(Mendonca and Lago, 1998). Auditory Evoked 
Potentials (AEP) has been reported to accomplish 
many requirements for measurement of the level of 
anaesthesia. A development has been made to this 
system to obtain a single index which presents the 
morphology of the AEP and uses this index as the 
input signal for closed-loop anaesthesia during 
surgery in patients who did not receive 
neuromuscular blocking drugs (Kenny and 
Mantzaridis, 1999). A robust control of depth of 
anaesthesia was developed by Dumont et al. (2009) 
to design both robust and PID controllers based on 
fractional calculus to control the hypnotic state of 
anaesthesia with intravenous management of 
Propofol (Dumont et al., 2009). The objectives of 
these controllers are considered to compensate for 
the patient’s inherent drug response variability, to 
accomplish good output disturbance rejection, and 
to achieve good tracking to set point response (Ejaz 
and Jiann-Shiou, 2004). The infusion and the drug 
effect are represented by the pharmacokinetic and 
pharmacodynamics models (Bressan et al., 2007). 
 
Model Predictive Control (MPC) has been 
recognised, in process control, as a proven 
technology   capable   of   dealing   with   a   wide   
range   of multivariable constrained control 
problems.  Nevertheless, most industrial controllers 
are based on linear internal models, which limit 
their applicability. 
This paper demonstrates the control of depth of 
anaesthesia using model based predictive control 
technique and compares its performance with PID 
and internal model control (IMC) approaches. 
 
 
 
2. MODEL BASED PREDICTIVE 
CONTROL TECHNIQUE 
 A model based on a compartmental approach is 
used in this study. In each compartment, the drug 
concentration is homogeneous and there are 
exchanges between compartments. A three 
compartments model is used, in which the main 
compartment represents intravascular blood (blood 
within arteries and veins) and highly irrigated 
organs (such as heart, brain, liver and kidney). The 
two other compartments represent muscles, fat and 
other organs or tissues. The PK model consisting of 
3-compartment is provided below and shown in 
Figure-1 (Dumont et al., 2009). 
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where x  represents the amount of drug in the 
central compartment, x  and x  denote the amount 
of the drug in compartments two and three, 
respectively. Also    is equal to 
   
    
 and    is equal 
to 
 
  v 
. The constants kij represent the transfer rate 
of the drug from the i th  compartment to the 
j th compartment. The constant k   is the rate of the 
drug metabolism and  is the infusion rate of the 
anaesthetic drug into the central compartment. 
  
Compartment 2
V2 , X2
Nonlinear 
Drug/ Hill 
equation
Compartment 3
V3 , X3
Effect Site 
Compartment
Xe
 input 
(infusion)
Compartment 1
V1 , X1
Metabolism
X1 K13X1 K12 X3 K31X2 K21
X1 K10X1 K1e
Xe Ke0
  BIS
PK
PD
 
Figure 1 – Compartmental model of the patient 
The pharmacodynamics is characterized by a 
low-pass filter related to the central compartment 
concentration     in blood: 
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where     and     are constants and    is the 
amount of drug in the effect compartment and    is 
the plasma Propofol and and Remifentanil 
concentrations. 
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where      is the inverse of the effect-site 
compartment time constant and      is the half-
maximal effective concentration.   is a steepness of 
the concentration response relation. 
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where    represents the baseline value (conscious 
state without Propofol), which is typically set to 
100;      denotes the maximum effect achieved by 
the drug infusion;      is the drug concentration at 
half maximal effect and denotes the patient’s 
sensitivity to the drug; and   determines the 
steepness of the static nonlinearity. 
2.1. MODEL PREDICTIVE CONTROL 
The fundamental objective of MPC shown in 
Figure-2 is to determine the sequence of M future 
control policy (manipulated variable changes) so 
that the sequence of P predicted values (output 
variables) has minimal set-point tracking error 
(Shridhar and Cooper, 1997). The  main purpose  of  
the  non-linear  model  predictive  control is  to find  
the  future  optimal  drug infusion sequence in order 
to minimize a function based on a desired output 
trajectory over a prediction horizon to adjust the 
amount of medication given to improve recovery 
from anaesthesia (Yelneedi et al., 2009a). The cost 
function is the integral over the squares of the 
residuals between the models predicted outputs y 
and the set point values r over the prediction time. 
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Figure 2 – Model predictive control scheme 
 
where, r is the set-point of the target for the BIS, 
u is the controlled variable, the Propofol infusion 
rate (       ) given in [mL/h], y is the output, the 
DoA level given in [%], d is the disturbance 
(    
    ), the Remifentanil effect concentration 
given in [µg/mL], and     
    
 is the Propofol 
effect concentration given in [µg/mL]. 
 
Model Predictive Control (MPC) is currently the 
most accepted method for handling disturbances 
predicting and estimating changes (Jonker et al., 
2005). MPC plays an important role in solving such 
complex problems. The main elements of the 
method are plant model, constraints and objective 
function, as shown in Figure-3. The objective 
function is evaluated and the selection of controller 
is repeated until the optimum is obtained (Bequette, 
2007). 
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Figure 3 – The basic concept of model predictive control 
 
The technique requires solution of optimization 
problem at every sampling time, other constraints 
on the drug infusion can be added, such as, that the 
drugs (propofol) rate  are to remain constant during 
the last numbers of steps. A linear or quadratic cost 
functions will be used. Stability results are obtained 
on the same idea as made for linear systems. One or 
several of the following assumptions are made, 
terminal equality constraints, terminal cost function, 
terminal constraint set and dual mode control 
(infinite horizon): begin with MPC with a terminal 
constraint set, switch then to a stabilizing linear 
controller when the region of attraction of the linear 
controller is reached (Weber et al., 2004). 
Generally, an MPC algorithm consists of applying a 
control sequence that minimizes a multistage cost 
function. A typical formulation is 
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Subject to:           
                         
                      
 
                                      
                     
 
where, M and P as the lengths of the prediction 
and control horizons, Q and R are the weighting 
matrices for both BIS and input rate respectively. 
These Q and R can be used to tune the MPC 
controller to achieve the desired value between 
output performance and manipulated variable 
movement. 
 
MPC controllers are based on an optimal control 
problem.  Therefore, the weights used in the cost 
function should be determined. Another cost 
function for the MPC block in MATLAB (see 
equation (9)) has been used to improve the drug 
infusion during surgery (Cardoso and Lemos, 2008) 
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where,   is a diagonal matrix representing the 
input weight,    is a diagonal matrix representing 
the input rate weight,    is a diagonal matrix 
representing the output weight,               
         
    is the vector of values of the control 
signal over the control horizon,          
     
      
              
      
    is the vector of values of 
the desired control signal over the control horizon, 
                        
   is the vector of values 
of the rate of the control signal over the control 
horizon,                       
  is the vector of 
values of the output over the prediction horizon, 
                      
   is the vector of values of 
the reference over the prediction horizon,    is the 
weight factor on the slack variable (used to penalize 
the violation of the constraints), and   is the slack 
variable, a variable to turn the inequality into an 
equation, it allows the constraints to be violated by 
a certain amount. 
2.2. CONSTRAINTS AND TIME HORIZON  
The range of DoA signal is between 0 and 100% 
(initial signal is about 97.7%) and the Propofol 
infusion must be at a positive rate (a negative rate 
would mean that propofol was being taken from the 
patient). These constraints are summed as shown in 
Table 1. 
 
Table 1 - Model predictive controller constraints 
Variables Minimum Maximum 
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In reality, these are the basic constraints. The 
maximum drug infusion rate and the changes in the 
medication infusion rate are constrained by the 
apparatus and equipment, but these bounds are very 
high and are never reached in practice. 
The prediction horizon P has been chosen based 
on open-loop settling time, whereas control horizon 
M is chosen based on the value between faster 
response (large value of M) and robustness (small 
value of M).  Therefore, the chosen value for M is 
very small, compared to P.  To reject the 
disturbances that are due to patient-model 
mismatch, the patient model is augmented by the 
output disturbance model, which is an integrator 
that is driven by white noise. 
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The MPC parameters are output (BIS) weight, Q 
= 1; input rate (Propofol) weight, R = 0.8; 
prediction (output) horizon, P = 30; and control 
(input) horizon, M =3. These parameters have been 
chosen by using direct search optimization for 
hypnosis regulation. 
 
3. SIMULATION STUDY AND RESULTS 
The main tuning parameters are the control and 
prediction horizons (M and P) and the weight 
applied to manipulated and control variables. 
The prediction horizon determines the amount of 
predictions that are used in the optimisation 
calculations. Increasing the prediction horizon 
results in more conservative control action that has 
a stabilising effect, also increases the computional 
efforts (Yelneedi et al., 2009b). A very large 
predication horizon recommended only for a very 
good model and if feedback is limited. 
 
The control horizon determines the number of 
future control actions that are calculated in the 
optimisation step to minimise the predicted errors. 
A large number for the control horizon, relatively to 
the prediction horizon, tends to too much control 
actions, but small value for control horizon leads to 
a robust controller. 
 
The model predictive control simulation design 
shown in Figure-4, the patient model has been used 
to estimate the value of the output variable BIS. The 
difference between the measured BIS from the 
process model and the model output, serves as the 
feedback signal to the prediction part. With this 
model output and input variable, the prediction part 
estimates the future values of the output BIS. Base 
on the predicted BIS values, the MPC controller 
calculates the future input moves of which only first 
input move is implemented by the controller at 
current sampling instant. 
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Figure 4 – The model predictive control simulation design 
A Model Predictive Control system of Propofol 
and Remifentanil is constructed. The time that the 
BIS reaches the range of 50 ± 10, is called the 
settling time for the BIS during general anaesthesia. 
The specifications of the MP  system for the 
settling time range was between 5 and 10 mintues 
and the robutness was stable for all parameters 
obtained in the simulation results and is shown in 
Figure-5. 
The target value of BIS is between 60 and 40. 
Figure-5 shows a simulation result for a subject 
with the nominal parameters. The MPC system can 
maintain BIS at the relevant target levels and the 
settling time is within ten minutes. 
 
 
 
 
 
 
 
Figure 5 – The performance of the MPC for nominal patient 
The predicted plasma Propofol concentration 
(  
    
) has to be between 0.5 µg/ml and 5 µg/ml 
because it is the clinically accepted range (Absalom 
et al., 2002) that is not measured but estimated 
using the nominal patient model. 
 
The manipulated variables    (propofol infusion 
rate) is constrained between 0 and 20          
(Furutani et al., 2005, Sawaguchi et al., 2008). 
 
The tuning of the MPC design for the nominal 
patient’s data for DoA parameters shown in Table  . 
The MPC tuning parameters are M, and P, the input 
horizon and the prediction horizon respectively; Q 
and R, weighting coefficient for BIS and the 
weighting coefficient for the Propofol rate 
respectively. MPC controller performance for 
different tuning weights on the output variables and 
input variable rates for insensitive patients are 
shown in Figure-6. 
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Figure 6 – MPC controller performance for different R and Q 
weights 
 
Table 2 - Nominal patient’s data for DoA parameters (MARSH 
et al., 1991, Minto et al., 1997) 
Variable Default value Unit 
vc 0.228 [L/kg] 
    0.119     
    
    0.112     
    
    0.0419     
    
    0.055     
    
    0.0033     
    
    0.25     
    
    
     11.20 [µg/mL] 
    
    
 2.65 [µg/mL] 
   97.7 [%] 
  2.561  
 
The performance of MPC, IMC and PID for 
sensitive patients for the set-point tracking during 
the surgery period is shown in Figure-7. These three 
controllers (MPC, IMC and PID) are able to meet 
performance specifications in spite of the significant 
and reasonable variation in the model parameters 
such as inter-patient variability based on PK-PD 
model. 
 
Figure 7 – The performance of MPC, IMC and PID controllers 
for sensitive patient 
There is a variation in PK (based on age and 
weight) and PD (patient’s sensitivity to the drug) 
model parameters.This assumption is based on the 
inter-patient and intra-patient variability (Schnider 
et al., 1999). The PK variation is about 25% of the 
model’s parameters. In addition, simulation studies 
showed that the variability in PD parameters have 
more impact on BIS than the variability in PK 
parameters (Schüttler and Ihmsen, 2000). 
 
The simulations results show that an insensitive 
patient requires relatively more Propofol and 
Remifentanil dosages and responds slowly to those 
drugs (as shown in Figure 8 for four different 
insensitive patients from Table 3). 
Based on the PD parameters, changing the results 
shows that the higher      indicates the need for 
more Propofol and Remifentanil drugs to get the 
same hypnosis and analgesia levels. Also higher   
(3.122) indicates higher non-linearity, and lower 
    (0.239) represents slowness in response. 
 
A sensitive patient requires less drug dosage to 
get the same hypnosis and analgesia levels. In PD 
parameters, lower      indicates that less Propofol 
and Remifentanil are required to get the same level 
of hypnosis and analgesia. The lower amount of  , 
represents weak non-linearity in the system 
response. Higher amount of     indicates a quicker 
response. 
 
 
 
 
  
Figure 8 – The performance of MPC controllers for four 
insensitive patients 
The performance of the three controllers (MPC, 
IMC and PID) is checked for the 12 patients, the 
insensitive, nominal and sensitive patients. 
 
Table 3 - Patient PK-PD parameters for Remifentanil drug 
used in this study (Niño et al., 2009) 
Patient 
 
    
 
    
 
    
 
    
 
    
 
     
 
    
 
  
 
1 (sensitive) 0.38175 0.2715 0.24375 0.00975 0.0175 7.840 0.6708 1.757 
2 0.50900 0.3620 0.24375 0.01625 0.0105 7.840 0.6708 1.757 
3 0.63625 0.2715 0.24375 0.01300 0.0140 7.840 0.6708 1.757 
4 0.63625 0.2715 0.24375 0.01300 0.0140 7.840 0.6708 1.757 
5 0.63625 0.2715 0.24375 0.01300 0.0140 7.840 0.6708 1.757 
6 (Nominal) 0.50900 0.3620 0.19500 0.01300 0.0140 11.20 0.5160 2.510 
7 0.50900 0.3620 0.19500 0.01300 0.0140 11.20 0.5160 2.510 
8 0.50900 0.3620 0.14625 0.00975 0.0140 14.56 0.5160 1.757 
9 0.63625 0.2715 0.14625 0.01625 0.0175 11.20 0.5160 1.757 
10 0.38175 0.3620 0.19500 0.00975 0.0105 11.20 0.3612 1.757 
11 0.50900 0.2715 0.14625 0.00975 0.0105 14.56 0.3612 2.510 
12 
(Insensitive) 
0.63625 0.4525 0.14625 0.01625 0.0105 14.56 0.3612 3.263 
 
The Simulink model structure can be seen in 
Figure-9. 
 
 
 
 
 
 
 
 
Figure 8 – The Simulink model structure 
 
4. CONCLUSIONS 
In this paper, a model predictive control strategy 
has been developed for automatic regulation of 
hypnosis and analgesia using BIS as controlled 
variables. The controllers were designed based on a 
nominal patient model, and then tested for their 
effectiveness, ability and robustness on 12 patient 
parameters covering sensitive to insensitive patients 
and operating conditions by the use of Simulink 
simulation.  
The new models and control algorithms 
developed in this project is immediately useful in 
the development of new DoA control systems that 
have potential to greatly improve the comfort of 
patients, reduce the medical cost and avoid 
intraoperative awareness and all its consequences. 
The results show that the MPC controller is 
capable of improving Propofol and Remifentanil 
inductions by 20 to 25% compared to PID 
controller, 8 to 10% compared to The IMC, and 
better robustness in set-point tracking and 
disturbance rejection when implemented on 
different patient parameters. In addition, the MPC 
control scheme is easier to design and does not need 
any complicated mathematical calculations. 
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